ATPアッセイの世界市場予測：消耗品（キット、試薬、マイクロプレート）、機器（発光計、分光光度計）...市場調査レポートについてご紹介

1 Introduction (Page No. – 17)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.4 Markets Covered
1.5 Years Considered for the Study
1.6 Currency
1.7 Stakeholders
1.8 Limitations
2 Research Methodology (Page No. – 20)
2.1 Research Approach
2.1.1 Secondary Research
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Research
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Breakdown of Primaries
2.1.2.3 Key Industry Insights
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Data Triangulation Approach
2.4 Market Ranking Analysis
2.5 Assumptions for the Study
3 Executive Summary (Page No. – 28)
4 Premium Insights (Page No. – 32)
4.1 ATP Assays: Market Overview
4.2 ATP Assays Market: Geographic Growth Opportunities
4.3 Regional Mix: Market
4.4 Market: Developed Vs. Developing Markets
5 Market Overview (Page No. – 35)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Demand for ATP Assays in Pharmaceutical & Biotechnology Companies
5.2.1.2 Rising Investments in Pharmaceutical & Biotechnology R&D
5.2.1.3 Increasing Prevalence of Cancer
5.2.1.4 Shift From Culture-Based Tests to Rapid Tests
5.2.1.5 Rising Incidence and Prevalence of Chronic & Infectious Diseases
5.2.2 Restraints
5.2.2.1 High Cost of Instruments
5.2.3 Opportunities
5.2.3.1 Technology Enhancements in ATP Assay Probes
5.2.3.2 Growth Prospects in Emerging Markets
6 ATP Assays Market, By Product (Page No. – 41)
6.1 Introduction
6.2 Consumables & Accessories
6.2.1 Reagents & Kits
6.2.1.1 Wide Applications of Reagents & Kits Account for the Large Share of This Segment
6.2.2 Microplates
6.2.2.1 As Miniaturization of Microplates Provides High Utility Over Gel-Based Well Systems, Their Adoption is High in the Analytical and Life Science Industry
6.2.3 Other Consumables & Accessories
6.3 Instruments
6.3.1 Luminometers
6.3.1.1 Luminometers are Comparatively Low-Priced and Therefore Widely Adopted
6.3.2 Spectrophotometers
6.3.2.1 Spectrophotometers are Costlier Than Luminometers And, Therefore, Less-Preferred By End Users in the Market
7 ATP Assays Market, By Application (Page No. – 52)
7.1 Introduction
7.2 Contamination Testing
7.2.1 Need to Meet Regulatory Mandates for Contamination and Quality Testing is a Key Driver of Market Growth
7.3 Disease Testing
7.3.1 Growing Disease Incidence and Rising Awareness are Expected to Support Market Growth During the Forecast Period
7.4 Drug Discovery & Development
7.4.1 Increasing R&D Pipeline for Pharmaceutical Drugs Will Drive Market Growth
8 ATP Assays Market, By End User (Page No. – 58)
8.1 Introduction
8.2 Pharmaceutical & Biotechnology Companies
8.2.1 Growth in Drug R&D Pipelines to Increase the Focus of Pharma & Biotech Companies on Quality Control Measures—Driving Growth in the Market
8.3 Food & Beverage Industry
8.3.1 Incidents of Food Contamination Have Led to the Introduction of New Legislations for Food Safety Testing, Thereby Driving the Growth of the Market
8.4 Hospitals & Diagnostic Laboratories
8.4.1 Growing Demand for Early Diagnosis of Diseases is a Major Factor Driving the Adoption of ATP Assays
8.5 Academic & Research Institutions
8.5.1 ATP Assays are Used for Research Activities Related to the Growth Rate & Viability of Microorganisms
9 ATP Assays Market, By Region (Page No. – 65)
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 US to Dominate the North American Market
9.2.2 Canada
9.2.2.1 Availability of a Broad Range of Government Funding Programs to Support Life Science Research to Drive Market Growth
9.3 Europe
9.3.1 Germany
9.3.1.1 Demand for ATP Assays Will be Driven By the Large-Scale Outsourcing of Clinical Diagnostic Testing By Hospitals to Commercial Service Providers
9.3.2 France
9.3.2.1 Strong Agro-Food Sector and a Major Focus on Biotechnology R&D to Drive Market Growth in France
9.3.3 UK
9.3.3.1 UK has the Largest Pharmaceutical R&D Expenditure in Europe
9.3.4 Italy
9.3.4.1 High Cancer Burden to Increase the Demand for ATP Assays in Italy
9.3.5 Spain
9.3.5.1 Growth in the Personalized Medicine Sector and Clinical Diagnostics Market to Drive the Market in Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.1.1 High Incidence of Cancer to Increase the Demand for ATP Assays in Japan
9.4.2 China
9.4.2.1 Increasing Pharmaceutical R&D Investments in the Country to Support Market Growth
9.4.3 India
9.4.3.1 Growing Adoption of ATP Assay Techniques in Research and Clinical Applications to Drive Market Growth in India
9.4.4 Rest of Asia Pacific
9.5 Latin America
9.6 Middle East & Africa
10 Competitive Landscape (Page No. – 108)
10.1 Introduction
10.2 Market Ranking for Key Players in the ATP Assays Market
10.3 Competitive Leadership Mapping
10.3.1 Visionary Leaders
10.3.2 Innovators
10.3.3 Dynamic Differentiators
10.3.4 Emerging Companies
10.4 Competitive Situations and Trends
10.5 Competitive Assessment of R&D Expenditure
10.6 Product Portfolio Analysis
11 Company Profiles (Page No. – 118)
(Business Overview, Products Offered, Recent Developments, and MnM View)*
11.1 Thermo Fisher Scientific, Inc.
11.2 Promega Corporation
11.3 Merck KGaA
11.4 PerkinElmer, Inc.
11.5 Agilent Technologies, Inc.
11.6 Abcam PLC.
11.7 Lonza Group
11.8 Neogen Corporation
11.9 3M Company
11.10 Danaher Corporation
11.11 PromoCell GmbH
11.12 Geno Technology, Inc.
11.13 Abnova Corporation
11.14 AAT Bioquest, Inc.
11.15 BioThema AB
11.16 BioVision, Inc.
11.17 Hygiena, LLC.
11.18 Biotium
11.19 Creative Bioarray
11.20 Canvax Biotech S.L.
11.21 Elabscience
11.22 MBL International Corporation (A Subsidiary of Jsr Corporation)
11.23 Ruhof Corporation
*Details on Business Overview, Products Offered, Recent Developments, and MnM View Might Not be Captured in Case of Unlisted Companies.
12 Appendix (Page No. – 157)
12.1 Discussion Guide
12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.3 Available Customizations
12.4 Related Reports
12.5 Author Details